Legaspi, Hannilore V.
HRN: 04-64-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2022
CEFUROXIME 1.5GM (VIAL)
06/06/2022
06/07/2022
IV
1.5g
Q8 X 3 Doses
S/P NSVD With Episiorrhaphy Of 4th Degree Laceration
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes